T1	Outcomes 905 943	The mean number of chemotherapy cycles
T2	Outcomes 1119 1145	developed tumor recurrence
T3	Outcomes 1147 1171	The Median Survival time
T4	Outcomes 1228 1264	The proportion of patients surviving
T5	Outcomes 1440 1462	any clinical advantage
